Adenoid Cystic Carcinoma Market According to DelveInsight, the dynamics of the Adenoid Cystic Carcinoma market are expected to evolve in the coming...

Here is how Perspective Therapeutics (CATX) and Adma Biologics (ADMA) have performed compared to their sector so far this year.

FRIDAY, Aug. 16, 2024 -- For patients with hepatocellular carcinoma (HCC), immune checkpoint inhibitor (ICI) use prior to liver transplant (LT) does...

Beam Therapeutics (BEAM) reports mixed second-quarter results. The company remains focused on pipeline development.

Dr Graham Kelly's latest venture Filamon is developing next generation anti-inflammatory drugs specifically designed for age-related diseases.  ...

The installation of an advanced SGRT system represents a major advancement in cancer care for the Cape region.

Get a deeper insight into the potential performance of PTC Therapeutics (PTCT) for the quarter ended June 2024 by going beyond Wall Street's top...

Despite gaining regulatory approvals in many countries for the first ever CRISPR-based gene therapy, investors should remain wary of investing in...